JOY SAARI: Open Payments
NPI 1174516686 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 26 payments from 10 companies in 2025. Trend: 2023 $13 · 2024 $142 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $158 |
| Novo Nordisk Inc | 5 | $107 |
| Astellas Pharma US Inc | 3 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $78 |
| Lilly USA, LLC | 2 | $38 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Corium, LLC | 1 | $26 |
| PFIZER INC. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $17 |
Products named: UBRELVY, Ozempic, Veozah, Kerendia, QULIPTA, MOUNJARO, ZORYVE, Wegovy.
Industry payments across VA — which companies pay providers there.
